These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11078501)

  • 1. Sentinel nodes: clinical trial data needed.
    Krag D; Ashikaga T; Abrams J
    J Clin Oncol; 2000 Nov; 18(22):3873-4. PubMed ID: 11078501
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the positive axilla in 2017.
    Avisar E; Ozmen T
    Breast Cancer Res Treat; 2017 Jun; 163(3):413-415. PubMed ID: 28382401
    [No Abstract]   [Full Text] [Related]  

  • 3. How to handle positive sentinel nodes?
    Schmidt C
    J Natl Cancer Inst; 2010 Dec; 102(24):1820-1, 1823. PubMed ID: 21139099
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of routine axillary nodal sampling to predict survival outcomes in lymph node-negative (N0) breast cancer.
    Bland KI
    Ann Surg; 2003 Feb; 237(2):168-70. PubMed ID: 12560773
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

  • 6. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False negative sentinel node procedure established through palpation of the biopsy wound.
    Tanis PJ; Nieweg OE; Merkus JW; Peterse JL; Kroon BB
    Eur J Surg Oncol; 2000 Nov; 26(7):714-5. PubMed ID: 11078620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 13. Micrometastatic sentinel lymph node disease: do patients benefit or suffer harm from axillary lymph node dissection?
    Ziogas D; Zografos GC
    Ann Surg Oncol; 2010 Mar; 17(3):936-7; author reply 938. PubMed ID: 19937389
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for lymph node dissection in nonmetastatic breast cancer.
    Pesce C; Morrow M
    Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLN biopsy for large and/or multicentric breast cancers: should we worry?
    Cody HS
    Eur J Surg Oncol; 2011 May; 37(5):386-7. PubMed ID: 21388775
    [No Abstract]   [Full Text] [Related]  

  • 16. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
    Recht A
    Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
    Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
    Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the clinically node-negative axilla: what have we learned from the clinical trials?
    Pilewskie ML; Morrow M
    Oncology (Williston Park); 2014 May; 28(5):371-8. PubMed ID: 25004648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
    Ainsworth RK; Kollias J; Le Blanc A; De Silva P
    Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.